SERINA THERAPEUTICS INC. (SER) Stock Income Statement
NYSEARCA:SER - NYSE Arca - US81751A1088 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.00K | 142.00K | 30.00K | 140.00K | 360.00K | |||
| Minority Interest Expense | 66.00K | 8.00K | 60.00K | 0.00 | 10.00K | |||
| Cost Of Goods | N/A | 40.00K | 10.00K | 20.00K | 30.00K | |||
| Gross Profit | N/A | 102.00K | 20.00K | 130.00K | 340.00K | |||
| Operating Expenses | 17.10M | 10.06M | 7.00M | 8.17M | 10.43M | |||
| Research and Development | 7.48M | 603.00K | 890.00K | 1.33M | 3.58M | |||
| Selling, General, and Administrative Expenses | 9.62M | 9.33M | 5.97M | 6.71M | 6.72M | |||
| Operating Income | -17.05M | -9.96M | -6.98M | -8.04M | -10.10M | |||
| Interest Income/Expense | 5.61M | -4.90M | -3.34M | -1.10M | -400.00K | |||
| Other Income/Expense | 228.00K | -24.00K | -210.00K | 450.00K | 110.00K | |||
| Non Recurring Items | N/A | 73.00K | 0.00 | 110.00K | 0.00 | |||
| Income Before Taxes | -11.21M | -14.81M | -10.52M | -8.58M | -10.40M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | -150.00K | |||
| Net Income | -11.14M | -14.80M | -10.46M | -8.68M | -10.87M | |||
| EBITDA | -16.85M | -9.83M | -6.85M | -7.91M | -8.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.51 | -13.72 | -0.28 | -0.23 | -0.27 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 71.83% | 66.67% | 92.86% | 94.44% | |||
| Profit Margin | -19894.64% | -10424.65% | -34866.67% | -6200.00% | -3019.44% | |||
| Operating Profit Margin | -30442.86% | -7014.08% | -23266.67% | -5742.86% | -2805.56% | |||
All data in USD